
AtaiBeckley (ATAI)
NasdaqMarket Closed
AtaiBeckley Inc. is a clinical-stage biopharmaceutical company developing novel treatments for mental health disorders. Its work is centred on therapies that aim to act more rapidly, or offer a more convenient treatment experience, than many existing psychiatric medicines. The company’s pipeline is focused on conditions with substantial unmet need, including treatment-resistant depression and social anxiety disorder.
The company’s lead programmes include BPL-003, a mebufotenin benzoate nasal spray being studied for treatment-resistant depression, and VLS-01, a DMT buccal film also being developed for treatment-resistant depression. AtaiBeckley is also advancing EMP-01, an (R)-MDMA hydrochloride candidate for social anxiety disorder. These assets are in Phase 2 clinical development, meaning they are being evaluated for safety, dosing, and signs of efficacy in patient populations before any potential late-stage trials.
AtaiBeckley operates in a fast-evolving area of neuroscience that includes psychedelic-inspired and rapid-acting psychiatric therapies. Its candidates are notable not only for their active compounds but also for their delivery formats, such as nasal spray and buccal film, which are intended to make administration more practical in controlled clinical settings. The company’s strategy depends on generating convincing clinical data, navigating regulatory requirements, and demonstrating that its treatments can be used safely and effectively.
As a development-stage biotech, AtaiBeckley does not resemble a conventional revenue-driven healthcare business. Its valuation is closely linked to clinical trial outcomes, regulatory progress, financing needs, and the commercial potential of new approaches to serious mental health conditions.
Last updated
- Market Cap
- $2,656,272,822
- P/E
- —
- P/FCF
- —
- P/S
- —
- Enterprise Value
- —
- Sector
- Materials
- Industry
- Pharmaceutical Preparations
- Address
- C/O ATAI LIFE SCIENCES US, INC., NEW YORK, NY, 10119
Why Eli Lilly Stock Climbed Today
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
AtaiBeckley (ATAI) After Eli Lillys Bid Still Looks Fully Valued
Top Biotech Gainers: CDNA Soars On Medicare Policy, ATAI Acquired, ABT Lifts Outlook, APLM On Watch
AtaiBeckley (ATAI) Soars to 4-Year High on $3.8B Merger with Eli Lilly
AtaiBeckley Soars as Eli Lilly Agrees to $2.8 Billion Buyout
Stocks making the biggest moves midday: Manpower, Abbott, UnitedHealth, TSMC & more
Eli Lilly is acquiring psychedelic drug developer AtaiBeckley for $3.8 billion
Eli Lilly Trips Into Red-Hot Psychedelics Space With A Big Takeover
Eli Lilly to buy psychedelic drugmaker AtaiBeckley for up to $3.8 billion in bet on depression therapy
Stocks making the biggest moves premarket: UnitedHealth, TSMC, GE Aerospace, J.B. Hunt & more
Top Biotech Gainers: NXTC Soars On Merger Deal, BMGL Moves Past Nasdaq Woes, OTLK Awaits FDA Verdict
The Race to Commercialize the World’s Most Powerful Psychedelic
3 Psychedelic Stocks With Potential Clinical Trial Catalysts
What This $496,000 Insider Sale at AtaiBeckley Means Amid Roughly 100% Stock Run
AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026
AtaiBeckley Announces Additional Phase 2a Results for EMP-01 (oral R-MDMA) Showing Large and Consistent Improvements in Social Anxiety Disorder
AtaiBeckley to Participate in Upcoming Needham Healthcare Conferences
BPL-003 Demonstrates Rapid and Durable Antidepressant Effects in Treatment-Resistant Depression; Phase 2a Data Published in Journal of Psychopharmacology; Phase 3 Program on Track for Q2 2026 Initiation
AtaiBeckley Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business and Clinical Update
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- $2,656,272,822
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- —
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- —
- P/S
P/S ratio compares a company's share price to its revenue per share.
- —
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- —
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- —
- EPS
- —
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- —
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- —
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- —
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- —
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- —
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- —
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- —
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- —
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- —
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- —
Financial statements are not available for this listing.
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | PREM14A — AtaiBeckley Inc. | View Filing | |
| edgar index | SCHEDULE 13G — AtaiBeckley Inc. | View Filing | |
| edgar index | SCHEDULE 13D/A — AtaiBeckley Inc. | View Filing | |
| edgar index | 8-K — AtaiBeckley Inc. | View Filing | |
| edgar index | DEFA14A — AtaiBeckley Inc. | View Filing | |
| edgar index | DEFA14A — AtaiBeckley Inc. | View Filing | |
| edgar index | DEFA14A — AtaiBeckley Inc. | View Filing | |
| edgar index | DEFA14A — AtaiBeckley Inc. | View Filing | |
| edgar index | DEFA14A — AtaiBeckley Inc. | View Filing | |
| edgar index | DEFA14A — AtaiBeckley Inc. | View Filing | |
| edgar index | DEFA14A — AtaiBeckley Inc. | View Filing | |
| edgar index | DEFA14A — AtaiBeckley Inc. | View Filing | |
| edgar index | DEFA14A — AtaiBeckley Inc. | View Filing | |
| edgar index | DEFA14A — AtaiBeckley Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — AtaiBeckley Inc. | View Filing | |
| edgar index | 144 — AtaiBeckley Inc. | View Filing | |
| form 4 | Form 4 — HERSHBERG ROBERT | View Filing | |
| form 4 | Form 4 — HERSHBERG ROBERT | View Filing | |
| form 4 | Form 4 — HERSHBERG ROBERT | View Filing | |
| form 4 | Form 4 — HERSHBERG ROBERT | View Filing | |
| form 4 | Form 4 — HERSHBERG ROBERT | View Filing | |
| edgar index | 4 — AtaiBeckley Inc. | View Filing | |
| edgar index | 4 — AtaiBeckley Inc. | View Filing | |
| edgar index | 144 — AtaiBeckley Inc. | View Filing | |
| form 4 | Form 4 — Kochendoerfer Gerd | View Filing | |
| form 4 | Form 4 — Kochendoerfer Gerd | View Filing | |
| form 4 | Form 4 — Kochendoerfer Gerd | View Filing | |
| edgar index | 144 — AtaiBeckley Inc. | View Filing | |
| form 4 | Form 4 — Craig Kevin James | View Filing | |
| form 4 | Form 4 — Craig Kevin James | View Filing | |
| form 4 | Form 4 — Craig Kevin James | View Filing | |
| form 4 | Form 4 — Craig Kevin James | View Filing | |
| form 4 | Form 4 — Craig Kevin James | View Filing | |
| edgar index | 8-K — AtaiBeckley Inc. | View Filing | |
| edgar index | 4 — AtaiBeckley Inc. | View Filing | |
| edgar index | 4 — AtaiBeckley Inc. | View Filing | |
| edgar index | 4 — AtaiBeckley Inc. | View Filing | |
| edgar index | 4 — AtaiBeckley Inc. | View Filing | |
| edgar index | 4 — AtaiBeckley Inc. | View Filing | |
| edgar index | 4 — AtaiBeckley Inc. | View Filing | |
| edgar index | 4 — AtaiBeckley Inc. | View Filing | |
| edgar index | 4 — AtaiBeckley Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — JOHNSON SABRINA MARTUCCI | View Filing | |
| form 4 | Form 4 — Smiley Andrea Heslin | View Filing | |
| form 4 | Form 4 — Kalali Amir H | View Filing | |
| form 4 | Form 4 — Hoffman John Francis | View Filing | |
| form 4 | Form 4 — HERSHBERG ROBERT | View Filing | |
| form 4 | Form 4 — Fischer Laurent | View Filing | |
| form 4 | Form 4 — Braunstein Scott | View Filing | |
| form 4 | Form 4 — Braunstein Scott | View Filing | |
| form 4 | Form 4 — Angermayer Christian | View Filing | |
| edgar index | 8-K — AtaiBeckley Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — AtaiBeckley Inc. | View Filing | |
| edgar index | 10-Q — AtaiBeckley Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — AtaiBeckley Inc. | View Filing | |
| edgar index | DEFA14A — AtaiBeckley Inc. | View Filing | |
| edgar index | 4 — AtaiBeckley Inc. | View Filing | |
| edgar index | 144 — AtaiBeckley Inc. | View Filing | |
| form 4 | Form 4 — Craig Kevin James | View Filing | |
| form 4 | Form 4 — Craig Kevin James | View Filing | |
| form 4 | Form 4 — Craig Kevin James | View Filing | |
| form 4 | Form 4 — Craig Kevin James | View Filing | |
| form 4 | Form 4 — Craig Kevin James | View Filing | |
| edgar index | 4 — AtaiBeckley Inc. | View Filing | |
| form 4 | Form 4 — Apeiron Investment Group Ltd. | View Filing | |
| form 4 | Form 4 — Angermayer Christian | View Filing | |
| form 4 | Form 4 — Apeiron Investment Group Ltd. | View Filing | |
| form 4 | Form 4 — Angermayer Christian | View Filing | |
| form 4 | Form 4 — Apeiron Investment Group Ltd. | View Filing | |
| form 4 | Form 4 — Apeiron Investment Group Ltd. | View Filing | |
| form 4 | Form 4 — Angermayer Christian | View Filing |